دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0015-0282(21)01998-1
Volume 116, Issue 4, October 2021, Pages A4-A9
Transgender men: clinical care and implications in reproductive medicine: introduction
Dominiquede ZieglerM.D.aPetrade SutterM.D., Ph.D.b
doi : 10.1016/j.fertnstert.2021.07.007
Volume 116, Issue 4, October 2021, Pages 919-921
Medicolegal issues surrounding legal sex designations
Vadim M.ShteylerM.D.aEli Y.AdashiM.D., M.S.b
doi : 10.1016/j.fertnstert.2021.08.020
Volume 116, Issue 4, October 2021, Pages 922-923
Masculinizing gender-affirming surgery for trans men and non-binary individuals: what you should know
Darshan P.PatelM.D.aIsak A.GoodwinM.D.bOmerAcarM.D.cErvinKocjancicM.D.cJames M.HotalingM.D., M.S.a
doi : 10.1016/j.fertnstert.2021.07.004
Volume 116, Issue 4, October 2021, Pages 924-930
The uterus in transgender men
MarieCarbonnelM.D.aLeaKarpelPh.D.abBernardCordierM.D.bPaulPirteaM.D.aJean MarcAyoubiM.D., Ph.D.a
doi : 10.1016/j.fertnstert.2021.07.005
Volume 116, Issue 4, October 2021, Pages 931-935
Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men
PaulPirteaM.D.aJean MarcAyoubiM.D., Ph.D.aStephanieDesmedtM.D., Ph.D.bGuyT’SjoenM.D., Ph.D.c
doi : 10.1016/j.fertnstert.2021.07.1206
Volume 116, Issue 4, October 2021, Pages 936-942
Intramural myomas–related infertility: should the myomas be removed? Not easy to reach a consensus
JacquesDonnezM.D., Ph.D.
doi : 10.1016/j.fertnstert.2021.08.015
Volume 116, Issue 4, October 2021, Pages 943-944
Intramural myomas more than 3–4 centimeters should be surgically removed before in vitro fertilization
Marie-MadeleineDolmansM.D., Ph.D.abKeithIsaacsonM.D.cWenjiaZhangM.D.cStephanGordtsM.D.dMalcolm G.MunroM.D.eElizabeth A.StewartM.D.fghijkMathildeBourdonM.D., Ph.D.lmnPietroSantulliM.D., Ph.D.lmnJacquesDonnezM.D., Ph.D.op
doi : 10.1016/j.fertnstert.2021.08.016
Volume 116, Issue 4, October 2021, Pages 945-958
Iconic brands: standing the test of time with a little rebranding
Steven R.LindheimM.D., M.M.M.Samantha M.PfeiferM.D.Beth W.RackowM.D.JohnPetrozzaM.D.MarjanAttaranM.D.AndreaZuckermanM.D.ThomasWinterM.D.
doi : 10.1016/j.fertnstert.2021.08.022
Volume 116, Issue 4, October 2021, Pages 959-960
Avoiding Asherman’s syndrome: refining our approach to uterine evacuation
Martin F.FreedmanM.D.abWilliam D.SchlaffM.D.b
doi : 10.1016/j.fertnstert.2021.06.037
Volume 116, Issue 4, October 2021, Pages 961-962
Testicular sperm extraction vs. ejaculated sperm use for nonazoospermic male factor infertility
Lauren M.Kendall RauchfussM.D.aTanaKimM.D.aJessica L.BleessPA-CaMatthew J.ZiegelmannM.D.bChandra C.ShenoyM.D.a
doi : 10.1016/j.fertnstert.2021.05.087
Volume 116, Issue 4, October 2021, Pages 963-970
Should we use testicular sperm for intracytoplasmic sperm injection in all men with significant oligospermia?
Bobby B.NajariM.D., M.Sc.aNannanThirumavalavanM.D.bc
doi : 10.1016/j.fertnstert.2021.08.002
Volume 116, Issue 4, October 2021, Pages 971-972
Male vitamin D status and male factor infertility
NicoleBanksM.D.aFangbaiSunM.P.H.bStephen A.KrawetzPh.D.cR. MatthewCowardM.D., F.A.C.S.dPuneetMassonM.D.eJames F.SmithM.D., M.S.fJ.C.TrussellM.D.gNanetteSantoroM.D.hHepingZhangPh.D.bAnne Z.SteinerM.D., M.P.H.i
doi : 10.1016/j.fertnstert.2021.06.035
Volume 116, Issue 4, October 2021, Pages 973-979
Universal SARS-CoV-2 polymerase chain reaction screening and assisted reproductive technology in a coronavirus disease 2019 pandemic epicenter: screening and cycle outcomes from a New York City fertility center
JacquelynShawM.D.aJessicaTozourM.D., Ph.D.bJennifer K.BlakemoreM.D. M.Sc.aJamesGrifoM.D., Ph.D.a
doi : 10.1016/j.fertnstert.2021.05.109
Volume 116, Issue 4, October 2021, Pages 980-987
Providing fertility care at the epicenter of a pandemic: lessons learned from universal screening of in vitro fertilization patients
Jacqueline C.LeeM.D.Jennifer F.KawwassM.D.
doi : 10.1016/j.fertnstert.2021.06.021
Volume 116, Issue 4, October 2021, Pages 988-989
Impact of preimplantation genetic testing on obstetric and neonatal outcomes: a systematic review and meta-analysis
WenhuiHouM.D.aGaohuiShiB.S.bYuanlinMaM.D.bYongxiangLiuM.Sc.bManmanLuM.D.aXiuliFanM.Sc.cYingpuSunM.D.a
doi : 10.1016/j.fertnstert.2021.06.040
Volume 116, Issue 4, October 2021, Pages 990-1000
Hyaluronic acid–enriched transfer medium for frozen embryo transfer: a randomized, double-blind, controlled trial
Sofie Shuk FeiYungM.B.B.S.aShui FanLaiM.B.B.S.bMei TingLamM.B.B.S.bEllen Man WaLuiM.B.B.S.aJennifer Ka YeeKoM.B.B.S.aHang Wun RaymondLiM.D.aJacki Yuk YingWongB.Sc.bEstella Yee LanLauPh.D.aWilliam Shu BiuYeungPh.D.aErnest Hung YuNgM.D.a
doi : 10.1016/j.fertnstert.2021.02.015
Volume 116, Issue 4, October 2021, Pages 1001-1009
Effect of pre-pregnancy body mass index on neonatal outcomes in women undergoing autologous frozen-thawed embryo transfer
XiaoyanYangM.D.abBeihongZhengM.S.bYunWangM.D.a
doi : 10.1016/j.fertnstert.2021.03.044
Volume 116, Issue 4, October 2021, Pages 1010-1019
Serum calponin 2 is a novel biomarker of tubal ectopic pregnancy
RuiqingZhangM.D.aShuangdiLiM.D., Ph.D.bYanqiuWangM.D., Ph.D.cWenCaiM.D.dQinLiuM.D.bJiarongZhangM.D., Ph.D.a
doi : 10.1016/j.fertnstert.2021.05.101
Volume 116, Issue 4, October 2021, Pages 1020-1027
Detecting bombers and abnormal pregnancies: a lesson from the Royal Air Force
JonahBardosM.D., M.B.E.abMicah J.HillD.O.bcd
doi : 10.1016/j.fertnstert.2021.08.006
Volume 116, Issue 4, October 2021, Pages 1028-1029
Ureaplasma parvum alters the immune tolerogenic state in placental tissue and could cause miscarriage
Caline NovaisTeixeira OliveiraPh.D.abMaria Tânia S.OliveiraM.D.aHellen BragaMartins OliveiraPh.D.bLucas SantanaCoelho SilvaM.D.bManoel NeresSantos JúniorM.D.bCarolline FlorentinoAlmeidaB.Sc.aAline TeixeiraAmorimPh.D.cMárcio VasconcelosOliveiraPh.D.aJorgeTimenetskyPh.D.cGuilherme BarretoCamposPh.D.aLucas MirandaMarquesPh.D.a
doi : 10.1016/j.fertnstert.2021.05.108
Volume 116, Issue 4, October 2021, Pages 1030-1039
Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans
YongkangYangM.D.abJiamingWuM.S.cdXiaWangM.M.bJianyuYaoM.S.efKim ShijianLaoPh.D.gYumeiQiaoB.N.bYingXuM.D.hYueHuM.M.cdYanhongFengM.M.bYanchaoCuiB.M.bShuaiShiM.M.bJingZhangM.M.bManLiangM.M.bYongPanPh.D.iKangXieM.S.efKaixuanYanM.S.efQinLiM.M.abDeweiYePh.D.efYaoWangPh.D.cd
doi : 10.1016/j.fertnstert.2021.05.098
Volume 116, Issue 4, October 2021, Pages 1040-1049
Vaginal ultrasound obsolete? Fibroblast growth factor 21 as a new diagnostic tool in missed abortion
KilianVomsteinM.D.ElisabethReiserM.D.BettinaTothM.D.
doi : 10.1016/j.fertnstert.2021.07.1207
Volume 116, Issue 4, October 2021, Pages 1050-1051
Impact of ambient temperature on ovarian reserve
Audrey J.GaskinsSc.D.aLidiaMínguez-AlarcónPh.D.bTrangVoPhamPh.D.cJaime E.HartSc.D.bdJorge E.ChavarroMD, Sc.D.defJoelSchwartzPh.D.bdeIreneSouterMDgFrancineLadenSc.D.bde
doi : 10.1016/j.fertnstert.2021.05.091
Volume 116, Issue 4, October 2021, Pages 1052-1060
Smoking, alcohol and coffee consumption and pregnancy loss: a Mendelian randomization investigation
ShuaiYuanB.Med., M.Med.Sc.aJinLiuM.D.bSusanna C.LarssonPh.D.ac
doi : 10.1016/j.fertnstert.2021.05.103
Volume 116, Issue 4, October 2021, Pages 1061-1067
Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men
SylvieLiermanB.M.L.S.aAnneliesTolpeM.B.S.aIlseDe CrooM.B.S.aStefanieDe GheselleM.B.aJustineDefreyneM.D., Ph.DbMachteldBaetensM.B.S.cAnneliesDheedenePh.D.cRoosColmanPh.D.dBjörnMentenPh.D.cGuyT’SjoenM.D.bPetraDe SutterM.D.aKellyTillemanPh.D.a
doi : 10.1016/j.fertnstert.2021.03.009
Volume 116, Issue 4, October 2021, Pages 1068-1076
Frozen eggs: national autologous oocyte thaw outcomes
Jennifer F.KawwassM.D.aSaraCrawfordPh.D.bHeather S.HippM.D.a
doi : 10.1016/j.fertnstert.2021.05.080
Volume 116, Issue 4, October 2021, Pages 1077-1084
Delayed treatment or deferred treatment: What’s intended? A commentary on national oocyte thaw outcomes data
EricFlisserM.D.
doi : 10.1016/j.fertnstert.2021.08.001
Volume 116, Issue 4, October 2021, Pages 1085-1086
Fertility preservation in childhood and adolescent female tumor survivors
FrancescaFilippiM.D.aCristinaMeazzaM.D.bEdgardoSomiglianaM.D., Ph.D.acMartaPoddaM.D.bChiaraDallagiovannaM.D.acMauraMassiminoM.D.bFrancescoRaspagliesiM.D.dMonicaTerenzianiM.D.b
doi : 10.1016/j.fertnstert.2021.06.012
Volume 116, Issue 4, October 2021, Pages 1087-1095
Oocyte cryopreservation in women after childhood and adolescent cancer
HuiyingLiM.D.aWenpeiXiangPh.D.abHuai L.FengPh.D.c
doi : 10.1016/j.fertnstert.2021.08.003
Volume 116, Issue 4, October 2021, Pages 1096-1097
Use of cryopreserved ovarian tissue in the Danish fertility preservation cohort
Stine GryKristensenPh.D.aYuWakimotoPh.D.adLotte BerdiinColmornPh.D.bMargitDueholmPh.D.eSusanne ElisabethPorsPh.D.aKirsten TrydeMacklonPh.D.bLinn SaltoMamsenPh.D.aDmitryNikiforovPh.D.aJesúsCadenasPh.D.aVinnie HornshøjGreveM.D.eAnne-MetteBay BjørnPh.D.fMikkelRosendahlPh.D.cAnette TønnesPedersenPh.D.cAndersNyboe AndersenD.M.Sc.bJensFedderPh.D.gErikErnstPh.D.fClaus YdingAndersenD.M.Sc.a
doi : 10.1016/j.fertnstert.2021.05.096
Volume 116, Issue 4, October 2021, Pages 1098-1106
Medical treatment of uterine arteriovenous malformation: a systematic review and meta-analysis
AdamRosenaWilson VenturaChanaJohnMatelskiM.Sc.bChrisWalshaAllyMurjiM.D. M.P.H.a
doi : 10.1016/j.fertnstert.2021.05.095
Volume 116, Issue 4, October 2021, Pages 1107-1116
Unconventional treatment of uterine arteriovenous malformation: the challenge of generating evidence for a rare condition
Mohamed A.BedaiwyM.D., Ph.D.
doi : 10.1016/j.fertnstert.2021.08.013
Volume 116, Issue 4, October 2021, Pages 1117-1118
Unmet financial burden of infertility care and the impact of state insurance mandates in the United States: analysis from a popular crowdfunding platform
Jeremy D.LaiM.D., M.B.A.aRichard J.FantusM.D.aAndrew J.CohenM.D.bVivianWanB.A.aMatthew T.HudnallM.D., M.P.H.aMinhPhamM.D.aRobert E.BranniganM.D.aJoshua A.HalpernM.D., M.S.a
doi : 10.1016/j.fertnstert.2021.05.111
Volume 116, Issue 4, October 2021, Pages 1119-1125
Crowdfunding a baby: hashtagging to bridge the gap between insured and under/uninsured fertility care
AmaliaNamathM.D.JenniferHirshfeld-CytronM.D., M.S.C.I.
doi : 10.1016/j.fertnstert.2021.08.004
Volume 116, Issue 4, October 2021, Pages 1126-1127
Early effects of the COVID-19 pandemic on fertility preferences in the United States: an exploratory study
Christine H.NayaM.P.H.aDarby E.SaxbePh.D.bGenevieve F.DuntonPh.D.ab
doi : 10.1016/j.fertnstert.2021.05.092
Volume 116, Issue 4, October 2021, Pages 1128-1138
Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine–cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome
Chi-ChangJuanPh.D.abKuo-HuChenM.D.cdChien-WeiChenPh.D.eChi-HongHoM.D., Ph.D.fgPeng-HuiWangM.D., Ph.D.fgHarn-ShenChenM.D., Ph.D.hiJiann-LoungHwangM.D.jklYu-HungLinM.D.jkmKok-MinSeowM.D., Ph.D.gj
doi : 10.1016/j.fertnstert.2021.05.093
Volume 116, Issue 4, October 2021, Pages 1139-1146
Systemic chronic subclinical inflammation, adipose tissue dysfunction, and polycystic ovary syndrome: three major forces intertwined
RicardoAzzizM.D., M.P.H., M.B.A.
doi : 10.1016/j.fertnstert.2021.08.017
Volume 116, Issue 4, October 2021, Pages 1147-1148
Antimüllerian hormone to determine polycystic ovarian morphology
AlexandraDietz de LoosM.D.aMartinHundPh.D.bKatharinaBuckPh.D.cCindyMeunM.D.aJohannaSillmanPh.D.bJoop S.E.LavenM.D.a
doi : 10.1016/j.fertnstert.2021.05.094
Volume 116, Issue 4, October 2021, Pages 1149-1157
Toward a universal serum antimüllerian hormone threshold as a surrogate for polycystic ovarian morphology on ultrasound: the story is not over…
DidierDewaillyM.D.
doi : 10.1016/j.fertnstert.2021.08.005
Volume 116, Issue 4, October 2021, Pages 1158-1159
Tryptophan catabolism is dysregulated in leiomyomas
Tsai-DerChuangPh.D.DerekQuintanillaB.S.DrakeBoosB.S.OmidKhorramM.D., Ph.D.
doi : 10.1016/j.fertnstert.2021.05.081
Volume 116, Issue 4, October 2021, Pages 1160-1171
Pregnancy prediction performance of an annotation-free embryo scoring system on the basis of deep learning after single vitrified-warmed blastocyst transfer: a single-center large cohort retrospective study
SatoshiUenoPh.D.aJørgenBerntsenM.Sc.bMotokiItoM.Sc.aKazuoUchiyamaM.T.aTadashiOkimuraB.Sc.aAkikoYabuuchiPh.D.aKeiichiKatoM.D., Ph.D.a
doi : 10.1016/j.fertnstert.2021.06.001
Volume 116, Issue 4, October 2021, Pages 1172-1180
Live births after Asherman syndrome treatment
Miriam M.F.HanstedeM.D.aEvavan der MeijM.D., Ph.D.aSebastiaanVeersemaM.D., Ph.D.bMark HansEmanuelM.D., Ph.D.b
doi : 10.1016/j.fertnstert.2021.05.099
Volume 116, Issue 4, October 2021, Pages 1181-1187
Pregnancy-related intrauterine adhesion treatment: new insights
Grigoris F.GrimbizisM.D., Ph.D.aAttilioDi Spiezio SardoM.D., Ph.D.bRudiCampoM.D.c
doi : 10.1016/j.fertnstert.2021.08.010
Volume 116, Issue 4, October 2021, Page 1188
Minimally invasive surgical management of a cornual ectopic pregnancy, with and without a concurrent intrauterine pregnancy
Stephanie I.DelgadoM.D.TamisaKoythongM.D.XiaomingGuanM.D.
doi : 10.1016/j.fertnstert.2021.06.007
Volume 116, Issue 4, October 2021, Pages 1189-1190
The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis
LinlingZhuM.D.aXinyunYangM.D.bBenbenCaoM.D.aShanshanTangM.D.aJinyiTongM.D.a
doi : 10.1016/j.fertnstert.2021.05.113
Volume 116, Issue 4, October 2021, Pages 1191-1193
Surgical innovation begins at the end of your comfort zone
PietroBortolettoM.D.Phillip A.RomanskiM.D.Rony T.EliasM.D.
doi : 10.1016/j.fertnstert.2021.07.1208
Volume 116, Issue 4, October 2021, Page 1194
Retro cervical tunneling to ensure correct placement for robotic-assisted transabdominal cerclage
ElenaSuárez-SalvadorPh.D.MariaGoyaPh.D.UrsulaAcostaM.D.MireiaVargasM.D.MelissaBradburyPh.D.ElenaCarrerasPh.D.AntonioGil-MorenoPh.D.
doi : 10.1016/j.fertnstert.2021.08.021
Volume 116, Issue 4, October 2021, Pages 1195-1196
“Nerve-sparing” laparoscopic treatment of parametrial ectopic pregnancy
GiovanniDi LorenzoM.D., Ph.D.aFedericoRomanoM.D., Ph.D.aGiuseppeMirendaM.D.bFrancescoCraccoM.D.bFrancescaBuonomoM.D.aGuglielmoStabileM.D., Ph.D.aStefanoFacchinM.D.cGiuseppeRicciM.D.ab
doi : 10.1016/j.fertnstert.2021.05.106
Volume 116, Issue 4, October 2021, Pages 1197-1199
A management algorithm and proposed pathogenesis for retroperitoneal ectopic pregnancies
KathrynCoyneM.D.RebeccaFlycktM.D.JosephFindleyM.D.
doi : 10.1016/j.fertnstert.2021.08.012
Volume 116, Issue 4, October 2021, Pages 1200-1201
